These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in sepsis. Namath A; Patterson AJ Crit Care Nurs Clin North Am; 2011 Mar; 23(1):181-202. PubMed ID: 21316575 [TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in sepsis. Namath A; Patterson AJ Crit Care Clin; 2009 Oct; 25(4):835-56, x. PubMed ID: 19892256 [TBL] [Abstract][Full Text] [Related]
6. Cytokine promoter polymorphisms in severe sepsis. Stuber F; Klaschik S; Lehmann LE; Schewe JC; Weber S; Book M Clin Infect Dis; 2005 Nov; 41 Suppl 7():S416-20. PubMed ID: 16237640 [TBL] [Abstract][Full Text] [Related]
7. Effects of genomic polymorphisms on the course of sepsis: is there a concept for gene therapy? Stüber F J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S60-4. PubMed ID: 11251034 [TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor type 1 gene polymorphism and sepsis. Hermans PW; Hazelzet JA Clin Infect Dis; 2005 Nov; 41 Suppl 7():S453-8. PubMed ID: 16237647 [TBL] [Abstract][Full Text] [Related]
9. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Renner P; Roger T; Calandra T Clin Infect Dis; 2005 Nov; 41 Suppl 7():S513-9. PubMed ID: 16237655 [TBL] [Abstract][Full Text] [Related]
11. Genomic polymorphism and sepsis--is there a reason for optimism? Průcha M; Zazula R; Peková S Prague Med Rep; 2008; 109(2-3):113-26. PubMed ID: 19548592 [TBL] [Abstract][Full Text] [Related]
12. A CXCL2 tandem repeat promoter polymorphism is associated with susceptibility to severe sepsis in the Spanish population. Flores C; Maca-Meyer N; Pérez-Méndez L; Sangüesa R; Espinosa E; Muriel A; Blanco J; Villar J; ; Genes Immun; 2006 Mar; 7(2):141-9. PubMed ID: 16421598 [TBL] [Abstract][Full Text] [Related]
13. Genetic variation and risk of sepsis. Kellum JA; Angus DC Minerva Anestesiol; 2003 Apr; 69(4):245-53. PubMed ID: 12766715 [TBL] [Abstract][Full Text] [Related]
14. The molecular genetic approach to malarial pathogenesis and immunity. Kwiatkowski D Parassitologia; 1999 Sep; 41(1-3):233-40. PubMed ID: 10697861 [TBL] [Abstract][Full Text] [Related]
15. Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis. Jessen KM; Lindboe SB; Petersen AL; Eugen-Olsen J; Benfield T BMC Infect Dis; 2007 Sep; 7():108. PubMed ID: 17877801 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme insertion/deletion polymorphism does not alter sepsis outcome in ventilated very low birth weight infants. John Baier R; Loggins J; Yanamandra K J Perinatol; 2005 Mar; 25(3):205-9. PubMed ID: 15549142 [TBL] [Abstract][Full Text] [Related]
17. Health-related disparities: influence of environmental factors. Olden K; White SL Med Clin North Am; 2005 Jul; 89(4):721-38. PubMed ID: 15925646 [TBL] [Abstract][Full Text] [Related]
18. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Laupland KB; Kirkpatrick AW; Delaney A Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465 [TBL] [Abstract][Full Text] [Related]